NYSE + Korea Exchange Agree to MOU for Business Collaboration: NYSE Content Update
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Sept. 3, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. Jason Tartick recently partnered with...
Neurophet Appoints Leading U.S. Dementia Imaging Expert Dr. Ana M. Franceschi as Scientific Advisor
Dr. Franceschi currently serves as Director of Dementia Imaging and Director of Molecular Neuroimaging at Northwell Health, where she has led advances in brain MRI and PET imaging technologies Neurophet aims to strengthen the clinical evidence for its key products and accelerate its expansion into the North American market, enhancing...
NUHS AND ITS INSTITUTIONS SECURE GOLD AND MULTIPLE AWARDS AT HOSPITAL MANAGEMENT ASIA AWARDS 2026
Six projects from across the healthcare cluster honoured for community impact, healthcare technology, sustainability and talent development SINGAPORE, Sept. 3, 2026 /PRNewswire/ -- To nurture a future-ready healthcare workforce, the National University Hospital (NUH) developed a scalable and sustainable leadership development system that strengthens leadership capability and builds a strong pipeline...
ZEISS elevates ophthalmic workflows at ESCRS with new surgical and digital advancements
ZEISS Medical Technology will showcase new clinical and digital workflow innovations at ESCRS, including: New ZEISS IOL offering is the world's first bitoric hydrophobic monofocal IOL with a non-constant asphericity profile design to treat cataracts while simultaneously correcting astigmatism. The EVA NEXUS™ from ZEISS now comes in a cataract-only configuration and...
Pulnovo Medical Announces Results of the PADN-HF-PH Trial at ESC Congress 2026, Simultaneously Published in The New England Journal of Medicine (NEJM)
Clinical outcomes from 264 PH-LHD patients demonstrate a 51% reduction in the risk of clinical worsening, a 35.5% decrease in recurrent clinical events, and sustained concurrent improvements in functional capacity, supporting the multi-dimensional therapeutic benefits of the Pulmonary Artery Denervation (PADN) System. SHANGHAI, Sept. 3, 2026 /PRNewswire/ -- Pulnovo Medical announced that groundbreaking results from the PADN-HF-PH trial...
FutureCeuticals , Inc. (FC) and Aura Scientific Resolve Coffee Fruit Patent Dispute, Recognize FC Patent Rights, and Initiate Seamless Transition to CognatiQ®
MOMENCE, Ill., Sept. 3, 2026 /PRNewswire/ -- FutureCeuticals, Inc. (FC) and Aura Scientific (Aura) are pleased to announce the resolution of FutureCeuticals' patent and trademark suit related to Aura's NeuroRush® ingredient and FutureCeuticals' whole coffee fruit extract marketed under the tradenames CognatiQ® and NeuroFactor®. "We are pleased that Aura has...
Tucker Medical selects GE HealthCare MRI technology to advance personalized preventive care in Singapore
Collaboration will explore clinical education, knowledge exchange and imaging excellence across Southeast Asia Tucker Medical has installed a SIGNA™ 1.5T magnetic resonance imaging system at its Novena Specialist Center in Singapore to support its personalized, risk-informed approach to assessment and screening. Through a memorandum of understanding, Tucker Medical and GE...
ClinHope Officially Establishes Hong Kong Branch to Strengthen Asia-Pacific Market Presence
TAIPEI, Sept. 3, 2026 /PRNewswire/ -- ClinHope today announced the official establishment of its Hong Kong branch. Following its operations in Taiwan and the United States, this marks another step in expanding into the Asian market and deepening its global service footprint. As the biotech, pharmaceutical, and medical device industries continue to move toward international development, ClinHope is...
In Indonesia, stroke care delays accumulate on the way to treatment, new report finds
Indonesian experts call for capability-based referral routing, greater investment in trained stroke teams and broader insurance coverage to close the gap between Western and Eastern Indonesia. JAKARTA, Indonesia, Sept. 3, 2026 /PRNewswire/ -- Structural delays occurring before patients reach treatment remain the biggest barrier to timely stroke care in Indonesia, according to a new report, Strengthening Stroke System Readiness...
Everest Medicines Announces China NMPA Approval of CARDAMYST® for the Conversion of Acute Symptomatic Episodes of Paroxysmal Supraventricular Tachycardia (PSVT) to Sinus Rhythm in Adults
SHANGHAI, Sept. 3, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that China's National Medical Products Administration (NMPA) has approved CARDAMYST® (etripamil) for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. As...
